Evidence map›Paper›PMID 30762109›Full record

ArticleEuropean radiology2019

Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.

Sameer Bhargava, Lars Andreas Akslen, Ida Rashida Khan Bukholm, Solveig Hofvind

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sameer BhargavaThe Cancer Registry of Norway, P.O. Box 5313, Majorstuen, 0304, Oslo, Norway.
Lars Andreas AkslenCentre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, Norway.
Ida Rashida Khan BukholmNorwegian System of Compensation to Patients, Oslo, Norway.
Solveig HofvindThe Cancer Registry of Norway, P.O. Box 5313, Majorstuen, 0304, Oslo, Norway. Solveig.Hofvind@kreftregisteret.no.ORCID http://orcid.org/0000-0003-0178-8939

Funding

EkstraStiftelsen Helse og Rehabilitering 2016/FO76429
6 · The paper itself

Abstract

objectivesTo explore performance measures among non-immigrants and immigrants attending BreastScreen Norway.

methodsWe analysed data from 2,951,375 screening examinations among non-immigrants and 153,026 among immigrants from 1996 to 2015. Immigrants were categorised into high- and low-incidence countries according to the incidence of breast cancer in their birth country. Performance measures, including attendance and recall rates, rates of screen-detected cancer (SDC) and interval breast cancer (IBC), positive predictive value (PPV) and histopathological tumour characteristics, were analysed. We used Fisher's exact model and t tests for descriptive statistics, and Poisson regression, adjusting for age and screening history, comparing results for non-immigrants versus immigrants.

resultsAttendance rates were 78% for non-immigrants and 56% for immigrants (p < 0.001). Rates of prevalent screens were 24% for non-immigrants and 32% for immigrants (p < 0.001). Immigrants from low-incidence countries were younger at diagnosis than non-immigrants (57 years versus 60 years, p < 0.001). Recall rates were 3.1% for non-immigrants and 3.8% for immigrants (p < 0.001), while PPVs were 17% and 14% (p < 0.001), respectively. IBCs in immigrants from low-incidence countries were more often triple negative (RR

conclusionImmigrants had lower attendance rates, higher recall rates and lower PPV than non-immigrants. The optimal age range and screening interval for immigrant women from low-incidence countries need to be further investigated. KEY POINTS: • Immigrants from countries with a low incidence of breast cancer had their breast cancer diagnosed at a younger age than non-immigrants. • Interval breast cancers detected in immigrants from countries with a low incidence of breast cancers were more often triple negative than those in non-immigrants. • The optimal age range and screening interval for immigrant women from low-incidence countries and non-immigrants might differ.

Indexed as

BreastBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingEarly Detection of CancerEmigrants and ImmigrantsFemaleHumansIncidenceMammographyMass ScreeningMiddle AgedNeoplasm InvasivenessNorwayPatient Acceptance of Health CarePrevalenceProspective StudiesBreast cancerEarly detection of cancerHealth care utilisationMammographyMass screening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.